2024
Synoptic operative reports for pediatric surgical oncology
Baertschiger R, Polites S, Fusco J, Roach J, Christison‐Lagay E, Malek M, Gow K. Synoptic operative reports for pediatric surgical oncology. Pediatric Blood & Cancer 2024, e31280. PMID: 39152638, DOI: 10.1002/pbc.31280.Peer-Reviewed Original ResearchImprove patient care outcomesElectronic medical record systemMultidisciplinary healthcare teamPatient care outcomesSurgical oncologySynoptic operative reportMedical record systemCare outcomesHealthcare teamPediatric surgical oncologyQuality assurance effortsDocumentation practicesData extractionDocumentation of surgical proceduresEffective communicationSynoptic reportingOperative notesRecording systemAssurance effortsEnhanced accessOncologyTumor characteristicsOperative reportsPediatric patientsResearch purposesCurrent surgical practice for central venous access to deliver chemotherapy and enteral access for nutritional support in pediatric patients with an oncological diagnosis
van den Bosch C, Grant C, Brown E, Morrison Z, Luques L, Christison‐Lagay E, Baertschiger R. Current surgical practice for central venous access to deliver chemotherapy and enteral access for nutritional support in pediatric patients with an oncological diagnosis. Pediatric Blood & Cancer 2024, e31206. PMID: 39030929, DOI: 10.1002/pbc.31206.Peer-Reviewed Original ResearchCentral venous catheterCentral venous accessPediatric patientsEnteral accessVenous accessNutritional supportTunneled central venous cathetersParenteral nutrition deliveryAdministration of chemotherapyLong-term outcomesCurrent surgical practiceDeterminants of outcomeSurgical oncology patientsModern oncology practiceCentral venous catheter managementDeliver chemotherapyVenous cathetersNutrition deliveryNutritional assessmentAccess surgerySurgical perspectiveOncological diagnosisOncology patientsNutritional statusSurgical practice
2015
Temsirolimus therapy and small bowel perforation in a pediatric patient with Clostridium septicum bacteremia
Herrin M, Rubinstein J, Christison-Lagay E. Temsirolimus therapy and small bowel perforation in a pediatric patient with Clostridium septicum bacteremia. Journal Of Pediatric Surgery Case Reports 2015, 3: 320-323. DOI: 10.1016/j.epsc.2015.05.014.Peer-Reviewed Original ResearchTemsirolimus therapyBowel perforationPediatric patientsLife-threatening side effectsSignificant disease stabilizationSmall bowel perforationCommon adverse effectsClostridium septicum infectionSmall bowel resectionHigh-grade gliomasBowel ischemiaDisease stabilizationBowel resectionSepticum infectionMetastatic rhabdomyosarcomaFrank necrosisSide effectsGastrointestinal pathogensTemsirolimusAdverse effectsPerforationPatientsRhabdomyosarcomaTherapyChildren
2013
Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: An institutional review
Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, La Quaglia MP. Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: An institutional review. Journal Of Pediatric Surgery 2013, 48: 757-763. PMID: 23583130, DOI: 10.1016/j.jpedsurg.2012.09.042.Peer-Reviewed Original ResearchConceptsSynovial sarcomaPulmonary metastasectomyPulmonary diseaseAdolescent patientsComplete resectionPulmonary metastasesBilateral pulmonary diseasePrimary tumor resectionTumor histological subtypeGreater OSSurgical metastasectomySurgical resectionImproved survivalPediatric patientsMetastatic lesionsTumor characteristicsHistological subtypesSurvival outcomesTumor resectionMetastasis diagnosisMetastasectomyResectionPatientsInstitutional reviewSurvival rate
2012
Prognostic Factors and Survival in Pediatric and Adolescent Liposarcoma
Stanelle EJ, Christison-Lagay ER, Sidebotham EL, Singer S, Antonescu CR, Meyers PA, La Quaglia MP. Prognostic Factors and Survival in Pediatric and Adolescent Liposarcoma. Sarcoma 2012, 2012: 870910. PMID: 22991488, PMCID: PMC3443598, DOI: 10.1155/2012/870910.Peer-Reviewed Original ResearchOverall survivalMargin statusPediatric patientsPrognostic factorsHistologic subtypeTumor gradeFive-year overall survivalMemorial Sloan-Kettering Cancer CenterPositive surgical marginsHigh tumor gradeMedian followAdjuvant therapyRecurrent diseasePeripheral tumorsMedian ageSurgical marginsPediatric populationCentral diseaseCentral tumorsPeripheral lesionsCancer CenterPrimary tumorTumor locationPoor survivalTreatment outcomes